Chemopreventive compounds--view from the other side
Jazyk angličtina Země Irsko Médium print-electronic
Typ dokumentu časopisecké články, práce podpořená grantem, přehledy
PubMed
19428340
DOI
10.1016/j.cbi.2009.01.003
PII: S0009-2797(09)00024-6
Knihovny.cz E-zdroje
- MeSH
- antikarcinogenní látky * terapeutické užití MeSH
- lidé MeSH
- nádory farmakoterapie patofyziologie prevence a kontrola MeSH
- rizikové faktory MeSH
- systém (enzymů) cytochromů P-450 metabolismus MeSH
- xenobiotika metabolismus terapeutické užití MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- přehledy MeSH
- Názvy látek
- antikarcinogenní látky * MeSH
- systém (enzymů) cytochromů P-450 MeSH
- xenobiotika MeSH
Increasing attention is being paid to the possibility of applying chemopreventive agents for the protection of individuals from cancer risk. The beneficial potential of chemoprotective compounds is usually well documented by extensive experimental data. To assure the desired effect, these compounds are frequently concentrated to produce dietary supplements for human use. The additive and synergistic effects of other food constituents are, however, frequently ignored. Even natural chemopreventive compounds have to be considered as xenobiotics. Thus, as much attention has to be paid to their testing prior to their wide application as is usual in drug development for human treatment. Unfortunately, much of the research in this area is solely based on simplified in vitro systems that cannot take into account the complexity of biotransformation processes, e.g. chemopreventive compound-drug interaction, effect on metabolism of endogenic compounds. Hence, the predicted chemopreventive potential is not attained in respect of cancer prevention; moreover, the administration of high doses of chemopreventive compounds might be even detrimental for the human health.
Citace poskytuje Crossref.org
The effects of selected flavonoids on cytochromes P450 in rat liver and small intestine